Array
(
[actionDate] => 2003-05-21
[displayText] => Reported (Amended) by the Committee on Education and the Workforce. H. Rept. 108-121.
[externalActionCode] => 5000
[description] => Introduced
[chamberOfAction] => House
)
Passed House
Array
(
[actionDate] => 2003-05-21
[displayText] => Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 425 - 1 (Roll no. 203).(text: CR H4382)
[externalActionCode] => 8000
[description] => Passed House
[chamberOfAction] => House
)
PDF(PDF provides a complete and accurate display of this text.)Tip?
Shown Here: Referred in Senate (05/22/2003)
[Congressional Bills 108th Congress]
[From the U.S. Government Printing Office]
[H.R. 1170 Referred in Senate (RFS)]
1st Session
H. R. 1170
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
May 22, 2003
Received; read twice and referred to the Committee on Health,
Education, Labor, and Pensions
_______________________________________________________________________
AN ACT
To protect children and their parents from being coerced into
administering a controlled substance in order to attend school, and for
other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Child Medication Safety Act of
2003''.
SEC. 2. REQUIRED POLICIES AND PROCEDURES.
(a) In General.--As a condition of receiving funds under any
program or activity administered by the Secretary of Education, not
later than 1 year after the date of the enactment of this Act, each
State shall develop and implement policies and procedures prohibiting
school personnel from requiring a child to obtain a prescription for
substances covered by section 202(c) of the Controlled Substances Act
(21 U.S.C. 812(c)) as a condition of attending school or receiving
services.
(b) Rule of Construction.--Nothing in subsection (a) shall be
construed to create a Federal prohibition against teachers and other
school personnel consulting or sharing classroom-based observations
with parents or guardians regarding a student's academic performance or
behavior in the classroom or school, or regarding the need for
evaluation for special education or related services under section
612(a)(3) of the Individuals with Disabilities Education Act (20 U.S.C.
1412(a)(3)).
SEC. 3. DEFINITIONS.
In this Act:
(1) Child.--The term ``child'' means any person within the
age limits for which the State provides free public education.
(2) State.--The term ``State'' means each of the 50 States,
the District of Columbia, and the Commonwealth of Puerto Rico.
SEC. 4. GAO STUDY AND REVIEW.
(a) Review.--The Comptroller General of the United States shall
conduct a review of--
(1) the variation among States in definitions of
psychotropic medication as used in regard to State jurisdiction
over public education;
(2) the prescription rates of medications used in public
schools to treat children diagnosed with attention deficit
disorder, attention deficit hyperactivity disorder, and other
disorders or illnesses;
(3) which medications used to treat such children in public
schools are listed under the Controlled Substances Act; and
(4) which medications used to treat such children in public
schools are not listed under the Controlled Substances Act,
including the properties and effects of any such medications
and whether such medications have been considered for listing
under the Controlled Substances Act.
(b) Report.--Not later than 1 year after the date of enactment of
this Act, the Comptroller General of the United States shall prepare
and submit a report that contains the results of the review under
subsection (a).
Passed the House of Representatives May 21, 2003.
Attest:
JEFF TRANDAHL,
Clerk.